WallStreetZen

NASDAQ: AZN
Astrazeneca Plc Stock Forecast, Predictions & Price Target

Analyst price target for AZN

Based on 1 analysts offering 12 month price targets for Astrazeneca Plc.
Min Forecast
$63.00+26.15%
Avg Forecast
$63.00+26.15%
Max Forecast
$63.00+26.15%

Should I buy or sell AZN stock?

Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AZN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Peter Welford
Jefferies
Strong BuyUpgradesN/AN/A2021-03-16
Michael Leuchten
UBS
Strong BuyUpgradesN/AN/A2021-02-25
Emmanuel Papadakis
Deutsche Bank
Strong BuyInitiates Coverage OnN/AN/A2021-01-15
Anonymous
Morgan Stanley
Strong BuyUpgradesN/AN/A2020-12-07
Andrew Berens
SVB Leerink
BuyMaintains$63.00+26.15%2021-03-02

1 of 1

Forecast return on equity

Is AZN forecast to generate an efficient return?
Company
35.9%
Industry
76.5%
Market
32,369.88%
AZN's Return on Equity is forecast to be high in 3 years (35.9%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AZN forecast to generate an efficient return on assets?
Company
8.41%
Industry
16.91%
Market
11,660.33%
AZN is forecast to generate lower Return on Assets (8.41%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast

AZN earnings per share forecast

What is AZN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.56+109.43%
Avg 2 year Forecast
$3.24+165.16%
Avg 3 year Forecast
$3.82+212.7%
AZN's earnings are forecast to grow at an exceptional rate of 46.6% per year
Forecast

AZN revenue forecast

What is AZN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$31.6B+18.69%
Avg 2 year Forecast
$35.8B+34.68%
Avg 3 year Forecast
$39.2B+47.22%
AZN's revenue is forecast to grow at a rate of 13.96% per year, which is not exceptional
Forecast

AZN earnings growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
46.6%
Industry
33.91%
Market
23.13%
AZN's earnings are forecast to grow faster (46.6% per year) than the US Drug Manufacturers - General industry average (33.91%)
Forecast
AZN's earnings are forecast to grow faster (46.6% per year) than the US market average (23.13%)
Forecast
AZN's earnings are forecast to grow faster (46.6% per year) than the risk-free savings rate (1.7%)
Forecast

AZN revenue growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
13.96%
Industry
5.95%
Market
15.05%
AZN's revenues are forecast to grow faster (13.96% per year) than the US Drug Manufacturers - General industry average (5.95%)
Forecast
AZN's revenues are forecast to grow slower (13.96% per year) than the US market average (15.05%)
Forecast

Astrazeneca Stock Forecast FAQ

Is Astrazeneca Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: AZN) stock is to Strong Buy AZN stock.

Out of 5 analysts, 4 (80%) are recommending AZN as a Strong Buy, 1 (20%) are recommending AZN as a Buy, 0 (0%) are recommending AZN as a Hold, 0 (0%) are recommending AZN as a Sell, and 0 (0%) are recommending AZN as a Strong Sell.

What is AZN's earnings growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual earnings growth rate of 46.6% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 33.91%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.13%.

Astrazeneca's earnings in 2021 is $3,144,000,000.On average, 4 Wall Street analysts forecast AZN's earnings for 2021 to be $3,352,160,000, with the lowest AZN earnings forecast at $3,161,920,000, and the highest AZN earnings forecast at $3,542,400,000. On average, 4 Wall Street analysts forecast AZN's earnings for 2022 to be $4,244,320,000, with the lowest AZN earnings forecast at $4,119,680,000, and the highest AZN earnings forecast at $4,368,960,000.

In 2023, AZN is forecast to generate $5,005,280,000 in earnings, with the lowest earnings forecast at $4,841,280,000 and the highest earnings forecast at $5,169,280,000.

What is AZN's revenue growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual revenue growth rate of 13.96% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.05%.

Astrazeneca's revenue in 2021 is $26,617,000,000.On average, 3 Wall Street analysts forecast AZN's revenue for 2021 to be $41,448,659,392,000, with the lowest AZN revenue forecast at $40,069,660,800,000, and the highest AZN revenue forecast at $42,188,672,000,000. On average, 3 Wall Street analysts forecast AZN's revenue for 2022 to be $47,031,612,992,000, with the lowest AZN revenue forecast at $44,312,537,600,000, and the highest AZN revenue forecast at $48,864,128,000,000.

In 2023, AZN is forecast to generate $51,412,688,000,000 in revenue, with the lowest revenue forecast at $50,281,088,000,000 and the highest revenue forecast at $52,544,288,000,000.

What is AZN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AZN) forecast ROA is 8.41%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.91%.

What is AZN's Price Target?

According to 1 Wall Street analysts that have issued a 1 year AZN price target, the average AZN price target is $63.00, with the highest AZN stock price forecast at $63.00 and the lowest AZN stock price forecast at $63.00.

On average, Wall Street analysts predict that Astrazeneca's share price could stay at $63.00 by Mar 16, 2022. The average Astrazeneca stock price prediction forecasts a potential downside of N/A from the current AZN share price of $49.94.

What is AZN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's current Earnings Per Share (EPS) is $1.22. On average, analysts forecast that AZN's EPS will be $2.56 for 2021, with the lowest EPS forecast at $2.41, and the highest EPS forecast at $2.70. On average, analysts forecast that AZN's EPS will be $3.24 for 2022, with the lowest EPS forecast at $3.14, and the highest EPS forecast at $3.33. In 2023, AZN's EPS is forecast to hit $3.82 (min: $3.69, max: $3.94).

What is AZN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AZN) forecast ROE is 35.9%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.